Antigua and Barbuda vs Tonga: Prevalence of anemia among women of reproductive age
Antigua and Barbuda
20.3%
in 2023
Tonga
20.7%
in 2023
Antigua and Barbuda rank
141st
Tonga rank
138th
Prevalence of anemia among women of reproductive age over time
- Antigua and Barbuda
- Tonga
How they compare
Tonga currently reports 20.7% against 20.3% in Antigua and Barbuda, a difference of 0.4%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 141st and Tonga ranks 138th of 192 countries.
Across the 3 decades both report, Antigua and Barbuda averaged higher in 1 and Tonga in 2.
Head to head by decade
| Decade | Antigua and Barbuda | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.0% | 18.5% | 3.5% | Antigua and Barbuda |
| 2010s | 18.1% | 18.2% | 0.2% | Tonga |
| 2020s | 19.6% | 19.9% | 0.3% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Antigua and Barbuda or Tonga?
- Tonga, at 20.7% against 20.3% in Antigua and Barbuda as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Antigua and Barbuda and Tonga?
- 0.4%, with Tonga ahead.
- How many years of comparable data are there for Antigua and Barbuda and Tonga?
- 24 years are reported by both, from 2000 to 2023.
- How do Antigua and Barbuda and Tonga rank globally for prevalence of anemia among women of reproductive age?
- Antigua and Barbuda ranks 141st and Tonga ranks 138th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.